We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

4 hedge funds and large institutions have $17K invested in Artelo Biosciences, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

35% less capital invested

Capital invested by funds: $26K → $17K (-$9K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.46K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$11K – – –
AGM
2
Alpine Global Management
New York
$4K – – –
UBS Group
3
UBS Group
Switzerland
$2K +$1.46K +4,567 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
– -$5K -12,402 Closed

ARTLW Hedge Fund Activity: Q2 2021 in Review

4 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q2 2021, worth a combined $17K — down 35% from $26K a quarter earlier.

Fund positioning in ARTLW was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $1.46K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $5K sold.

  • 4 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $17K of Artelo Biosciences, Inc. Warrant stock for Q2 2021, down 35% quarter-over-quarter.
  • 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q2 2021 and 1 closed out, a net change of 0 holders.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q2 2021 was UBS Group, an estimated $1.46K added.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q2 2021 was Susquehanna International Group, an estimated $5K sold.

Based on aggregated 13F filings for Q2 2021.